Carcinogenesis in an immunologically privileged site.
D000096:Acetone; D000287:Administration, Topical; D000818:Animals; D002610:Cheek / Q000601:surgery; D006224:Cricetinae; D004195:Disease Models, Animal; D004343:Drug Implants; D004431:Ear, External / Q000601:surgery; D005354:Fibrosarcoma / Q000276:immunology*; D007279:Injections, Subcutaneous; D007958:Leukocyte Count; D008748:Methylcholanthrene / Q000008:administration & dosage; D009369:Neoplasms / Q000139:chemically induced; D010212:Papilloma / Q000276:immunology*; D012513:Sarcoma, Experimental / Q000276:immunology; D012878:Skin Neoplasms / Q000276:immunology*; D016038:Skin Transplantation; D014182:Transplantation, Autologous
D004343:Drug Implants; D000096:Acetone; D008748:Methylcholanthrene